{"id":"NCT01774721","sponsor":"Pfizer","briefTitle":"ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.","officialTitle":"ARCHER 1050: A RANDOMIZED, OPEN-LABEL, PHASE 3, EFFICACY AND SAFETY STUDY OF DACOMITINIB (PF-00299804) VERSUS GEFITINIB FOR THE FIRST LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SUBJECTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATING MUTATION(S)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05-09","primaryCompletion":"2016-07-29","completion":"2022-01-27","firstPosted":"2013-01-24","resultsPosted":"2018-10-26","lastUpdate":"2023-11-14"},"enrollment":452,"design":{"allocation":"RANDOMIZED","model":null,"masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-small Cell Lung Cancer With EGFR-Activating Mutations"],"interventions":[{"type":"DRUG","name":"Dacomitinib (PF-00299804)","otherNames":["Dacomitinib"]},{"type":"DRUG","name":"Gefitinib","otherNames":["Iressa"]}],"arms":[{"label":"Dacomitinib (PF-00299804)","type":"EXPERIMENTAL"},{"label":"gefitinib","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multinational, multicenter, randomized, open-label, Phase 3 study comparing the efficacy and safety of treatment with dacomitinib (PF-00299804) to treatment with gefitinib in patients with locally advanced or metastatic non-small cell lung cancer, with epidermal growth factor receptor EGFR-activating mutation (s). Analyses of primary objective (Progression Free Survival) will be done as defined in the protocol.","primaryOutcome":{"measure":"Progression Free Survival (PFS) Based on Independent Radiologic Central (IRC) Review","timeFrame":"Day 28 of Cycle 1, Cycle 2 then every 8 weeks until disease progression or death due to any cause, whichever occurred first (up to 48 months)","effectByArm":[{"arm":"Dacomitinib","deltaMin":14.7,"sd":null},{"arm":"Gefitinib","deltaMin":9.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":52,"countries":["China","Hong Kong","Italy","Japan","Poland","South Korea","Spain"]},"refs":{"pmids":["39360943","34120312","33721611","33331989","31313942","31050691","29864379","28958502","26768165"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":69,"n":227},"commonTop":["Diarrhoea","Paronychia","Dermatitis acneiform","Alanine aminotransferase increased","Stomatitis"]}}